ערך בספרים למניה: tenayatherapeutics.com (TNYA)

Tenaya Therapeutics (TNYA) is a biotech developer creating gene restoration methods for cardiac tissues to combat hereditary pathologies. The firm's financial stability relies on external investments, as the company is currently in the clinical trial stage. This chart reflects an asset value of 0.31, while future pricing potential depends directly on patent exclusivity and regulatory approvals.

Tenaya Therapeutics (TNYA) investments in the development of cardiac gene therapy require significant capital, which directly impacts the company's net asset volume. The book value per share, reflected through the equity per common share chart, measures the difference between all assets and liabilities per security, allowing investors to assess the issuer's intrinsic value and the risk of capital drawdown.